Age and gender may affect posterior reversible encephalopathy syndrome in renal disease

Pediatric Nephrology

Volumn 27, Issue 2, 2012, Pages 277-283

  Yamada, Akio ^a   Ueda, Norishi ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age; Calcineurin inhibitors; Gender; Hypertension; Nephrotic syndrome; Posterior reversible encephalopathy syndrome; Renal insufficiency

Indexed keywords

ALBUMIN; CREATININE; METHYLPREDNISOLONE; PROTEIN; STEROID;

ACUTE GLOMERULONEPHRITIS; ADOLESCENT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ALPORT SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMA; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE DURATION; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SCHOOL CHILD; SEIZURE; SEX DIFFERENCE; VISUAL DISORDER;

ADOLESCENT; AGE FACTORS; CALCINEURIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; KIDNEY DISEASES; MALE; NEUROIMAGING; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 84857083943     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1974-y     Document Type: Article

References (31)

1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin M, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494-500 (Pubitemid 26067737)
2. Bartynski WS (2008) Posterior reversible encephalopathy syndrome. I. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036-1042 (Pubitemid 351954863)
3. Bartynski WS (2008) Posterior reversible encephalopathy syndrome. II. Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043-1049 (Pubitemid 351954864)
4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: Associated clinical and radiologic findings. Mayo Clin Proc 85:427-432
5. Roth C, Ferbert A (2010) Posterior reversible encephalopathy syndrome: Long-term follow-up. J Neurol Neurosurg Psychiatry 81:773-777
6. De Laat P, te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472-478
7. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M (2006) Posterior reversible encephalopathy syndrome in children: Its high prevalence and more extensive imaging findings. Am J Kidney Dis 48:231-238 (Pubitemid 44056328)
8. Ishimori ML, Pressman BD, Wallace DJ, Weisman MH (2007) Posterior reversible encephalopathy syndrome: Another manifestation of CNS SLE? Lupus 16:436-443 (Pubitemid 47122218)
9. Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22:1921-1929 (Pubitemid 47506233)
10. Ikeda M, Ito S, Hataya H, Honda M, Anbo K (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37:E30
11. Ishikura K, IkedaM, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M (2008) Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 23:2531-2536
12. Saeed B, Abou-Zor N, Amer Z, Kanani I, Hilal M (2008) Cyclosporin-A induced posterior reversible encephalopathy syndrome. Saudi J Kidey Dis Transpl 19:439-442
13. Nishida M, Sato H, Kobayashi N, Morimoto M, Hamaoka K (2009) Wernicke's encephalopathy in a patient with nephrotic syndrome. Eur J Pediatr 168:731-734
14. Kabicek P, Sulek S, Seidl Z, Vaneckova M, Kabickova E, Vobruba V, Wenchich L, Zeman J (2010) Posterior reversible encephalopathy syndrome (PRES) in 5-year-old girl with nephrotic syndrome. Neuro Endocrinol Lett 31:297-300
15. Akutsu N, Iwashita C, Maruyama M, Ootsuki K, Ito T, Saigo K, Kenmochi T (2008) Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients. Transpl Proc 40:2416-2418
16. Gijtenbeek JMM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: A review. J Neurol 246:339-346 (Pubitemid 29261421)
17. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D (2009) Posterior reversible encephalopathy syndrome: Do predisposing factors make a difference in MRI appearance? Neuroradiology 51:373-383
18. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 27:2179-2190 (Pubitemid 44788652)
19. Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: Impact and clinical management. Transplant Int 13:313-326
20. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
21. Awan AQ, Lewis MA, Postlethwaite RJ, Webb NJA (1999) Seizures following renal transplantation in childhood. Pediatr Nephrol 13:275-277 (Pubitemid 29243726)
22. Zheng W (2001) Neurotoxicology of the brain barrier system: New implications. Clin Toxicol 39:711-719 (Pubitemid 34016566)
23. Tuor UI, Grewal D (1994) Autoregulation of cerebral blood flow: Influence of local brain development and postnatal age. Am J Physiol 267:H2220-H2228
24. Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: Frequency, features, and risk factors. Stroke 41:2505-2511
25. Schmithorst VJ, Holland SK, Dardzinski BJ (2008) Developmental differences in white matter architecture between boys and girls. Hum Brain Mapp 29:696-710 (Pubitemid 351794124)
26. Besenski N, Rumboldt Z, Emovon O, Nicholas J, Kini S, Milutinovic J, Budisavljevic MN (2005) Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 26:2282-2289
27. Irvin W, MacDonald G, Smith JK, Kim WY (2007) Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 25:2484-2486 (Pubitemid 46999222)
28. Bai JPF, Lesko LJ, Burckart GJ (2010) Understanding the genetic basis for adverse effects: The calcineurin inhibitors. Pharmacotherapy 30:195-209
29. Pirker A, Kramer L, Voller B, Loader B, Auff E, Prayer D (2011) Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: An MR imaging study in 28 patients. AJNR Am J Neuroradiol 32:527-531
30. Girisgen I, Tosun A, Sönmez F, Özsunar Y (2010) Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysis. Turkish J Pediatr 52:416-419
31. Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK (2003) Is reversible posterior leukoencephalopathy syndrome with severe hypertension completely reversible in all patients? Pediatr Nephrol 18:1161-1166 (Pubitemid 37406866)